Neurology Central

Granulin research opens avenues for frontotemporal dementia treatment

Researchers from Emory University School of Medicine (GA, USA) have developed the first tool with the ability to detect granulins in cells. The discovery could open up avenues to new therapeutics for a wide range of age-related neurodegenerative diseases.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.